scholarly journals Clinical and Prognostic Significance of Tumor-Infiltrating CD8+ T Cells and PD-L1 Expression in Primary Gastrointestinal Stromal Tumors

2021 ◽  
Vol 11 ◽  
Author(s):  
Xiangfei Sun ◽  
Ping Shu ◽  
Yong Fang ◽  
Wei Yuan ◽  
Qiang Zhang ◽  
...  

PurposeImmunotherapy for gastrointestinal stromal tumors (GISTs) remains a clinical challenge. The present study aimed to explore the clinical and prognostic significance of immune cell infiltration and PD-L1 expression in GISTs.MethodsA total of 507 clinical tissue specimens of primary GISTs were collected for immunohistochemical analysis of immune cell infiltration and PD-L1 expression. Influencing factors of survival were evaluated by Kaplan–Meier analysis. Univariate and multivariate analyses were performed using the Cox regression model.ResultsThere were significant differences in sex, tumor location, size, mitotic index, NIH risk grade, and cell morphology between different gene mutation types of GISTs. Immune cell infiltration in GISTs mainly involved macrophages and T cells. PD-1 was expressed in 48.5% of the tissue specimens, and PD-L1 expression was detected in 46.0% of the samples. PD-L1 expression was negatively correlated with the tumor size and mitotic index but positively correlated with the number of CD8+ T cells. There were significant differences in the number of CD8+ T cells between different gene mutation types. Wild type-mutant GISTs were enriched with CD8+ T cells as compared with KIT- and PDGFRA-mutant GISTs. The number of CD8+ T cells was higher in non-gastric GISTs. PD-L1 and CD8+ T cells were independent predictors for better relapse-free survival of GISTs.ConclusionsPD-L1 expression is a predictive biomarker for better prognosis of GISTs. Non-gastric GIST patients with wild-type mutations may be the beneficiaries of PD-1/PD-L1 inhibitors.

2021 ◽  
Author(s):  
Zhihao Chen ◽  
Liubing Li ◽  
Ziyuan Li ◽  
Xi Wang ◽  
Mingxiao Han ◽  
...  

Abstract Background: The potential functions of circular RNAs (circRNAs) and micro RNAs (miRNAs) in osteosarcoma (OS) have not been fully elucidated. Especially, the behavior and mechanism of immune responses in OS development and progression have not been fully demonstrated. It was reported that circRNAs and miRNAs can serve as biomarkers for the diagnosis, prognosis, and therapy of many cancers. This study aimed to identify novel key serum biomarkers to diagnose and predict metastasis of OS based on the analysis of immune cell infiltration characteristics.Methods: The differentially-expressed circRNAs (DEcircRNAs), differentially-expressed miRNAs (DEmiRNAs),and differentially-expressed mRNAs (DEmRNAs) of human OS were investigated based on the microarray data downloaded from Gene Expression Omnibus (GEO) datasets. Then, we analyzed immune characteristics pattern of tumor-infiltrating immune cells in OS. On this basis, we identified statistically-significant transcription factors and performed pathway enrichment analysis. Subsequently, we constructed protein-protein interaction (PPI) and competitive endogenous RNA (ceRNA) networks. Moreover, the biological characteristic of targets in ceRNA networks was proposed. Finally, the expression and diagnostic capability of these potential biomarkers from ceRNA network were confirmed by RT-qPCR in patients’ serum.Results: Seven differentially-expressed circRNAs (DEcircRNAs), 166 differentially-expressed miRNAs (DEmiRNAs) and 175 differentially-expressed mRNAs (DEmRNAs) were identified in total. The highest level of infiltration in OS patients were M0 macrophages, M2 macrophages and CD8+ T cells. Further, M0 macrophages and CD8+ T cells were showed the largest negative correlation coefficients. These significant immune characteristics pattern of tumor-infiltrating immune cells were revealed by the principal component analysis in OS. Moreover, we found 185 statistically-significant transcription factors in which the main significant molecules show the potential in immunotherapy of OS. Hsa-circ-0010220, hsa-miR-326, hsa-miR-338-3p, and FAM98A from ceRNA networks associated with immune cell infiltration were confirmed as the potential novel biomarkers for OS diagnosis, of which FAM98A could distinguish and predict metastasis. Most importantly, a novel diagnostic model consisting of the four promising biomarkers (hsa-circ-0010220, hsa-miR-326, hsa-miR-338-3p, and FAM98A) was highlighted with 0.928 AUC value.Conclusions: In summary, the potenial serum biomarkers to diagnose and predict metastasis of OS based on the analysis of immune cell infiltration characteristics were found, and a novel diagnostic model consisting of four promising serum biomarkers was proposed firstly. These results provided a new perspective for the immunotherapy of OS.


2020 ◽  
Author(s):  
Naiqiang Zhu ◽  
Jingyi Hou

Abstract Background: Sarcomas, cancers originating from mesenchymal cells, are comprehensive tumors with poor prognoses, yet their tumorigenic mechanisms are largely unknown. In this study, we characterize infiltrating immune cells and analyze immune scores to identify the molecular mechanism of immunologic response to sarcomas.Method: The “CIBERSORT” algorithm was used to calculate the amount of L22 immune cell infiltration in sarcomas. Then, the “ESTIMATE” algorithm was used to assess the “Estimate,” “Immune,” and “Stromal” scores. Weighted gene co-expression network analysis (WGCNA) was utilized to identify the significant module related to the immune therapeutic target. Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using the “clusterProfiler” package in R for annotation and visualization. Results: Macrophages were the most common immune cells infiltrating sarcomas. The number of CD8 T cells was negatively associated with that of M0 and M2 macrophages, and positively associated with M macrophages in sarcomas samples. The clinical parameters (disease type, gender) significantly increased with higher Estimate, Immune, and Stromal scores, and with a better prognosis. The blue module was significantly associated with CD8 T cells. Functional enrichment analysis showed that the blue module was mainly involved in chemokine signaling and the PI3K-Akt signaling pathway. CD48, P2RY10 and RASAL3 were identified and validated at the protein level.Conclusion: Based on the immune cell infiltration and immune microenvironment, three key genes were identified, thus presenting novel molecular mechanisms of sarcoma metastasis.


2020 ◽  
Author(s):  
Naiqiang Zhu ◽  
Jingyi Hou

Abstract Background: Sarcomas, cancers originating from mesenchymal cells, are comprehensive tumors with poor prognoses, yet their tumorigenic mechanisms are largely unknown. In this study, we characterize infiltrating immune cells and analyze immune scores to identify the molecular mechanism of immunologic response to sarcomas.Method: The “CIBERSORT” algorithm was used to calculate the amount of L22 immune cell infiltration in sarcomas. Then, the “ESTIMATE” algorithm was used to assess the “Estimate,” “Immune,” and “Stromal” scores. Weighted gene co-expression network analysis (WGCNA) was utilized to identify the significant module related to the immune therapeutic target. Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using the “clusterProfiler” package in R for annotation and visualization. Results: Macrophages were the most common immune cells infiltrating sarcomas. The number of CD8 T cells was negatively associated with that of M0 and M2 macrophages, and positively associated with M macrophages in sarcomas samples. The clinical parameters (disease type, gender) significantly increased with higher Estimate, Immune, and Stromal scores, and with a better prognosis. The blue module was significantly associated with CD8 T cells. Functional enrichment analysis showed that the blue module was mainly involved in chemokine signaling and the PI3K-Akt signaling pathway. CD48, P2RY10 and RASAL3 were identified and validated at the protein level.Conclusion: Based on the immune cell infiltration and immune microenvironment, three key genes were identified, thus presenting novel molecular mechanisms of sarcoma metastasis.


2020 ◽  
Author(s):  
Naiqiang Zhu ◽  
Jingyi Hou

Abstract Background Sarcomas, cancers originating from mesenchymal cells, are comprehensive tumors with poor prognoses, yet their tumorigenic mechanisms are largely unknown. In this study, we aimed to characterize infiltrating immune cells and genes associated with the immunologic response to sarcomas. Method The “CIBERSORT” algorithm was used to calculate the amount of L22 immune cell infiltration in sarcomas. Then, the “ESTIMATE” algorithm was used to assess the “Estimate,” “Immune,” and “Stromal” scores. Weighted gene co-expression network analysis (WGCNA) was utilized to identify the significant module related to the immune therapeutic target. Gene ontology (GO) enrichment and Kyoto Encyclopedia of Gens and Genomes (KEGG) analysis were applied using the “clusterProfiler” package in R for annotation and visualization. Results Macrophages were the most common immune cells infiltrating sarcomas. The number of CD8 T cells was negatively associated with that of M0 and M2 macrophages, and positively associated with M macrophages in sarcomas samples. The clinical parameters (disease type, gender) significantly increased with higher Estimate, Immune, and Stromal scores, and with a better prognosis. The blue module was significantly associated with CD8 T cells. Functional enrichment analysis showed that the blue module was mainly involved in chemokine signaling and the PI3K-Akt signaling pathway. CD48, P2RY10 and RASAL3 were identified and validated at the protein level. Conclusion Based on the immune cell infiltration and immune microenvironment, three key genes were identified, which suggest novel molecular mechanisms of sarcoma metastasis.


2020 ◽  
Author(s):  
Biao Huang ◽  
Wei Han ◽  
Zu-Feng Sheng ◽  
Guo-Liang Shen

Abstract Background Skin cutaneous melanoma (SKCM) is one of the most malignancy and aggressive cancers, causing about 72% of deaths in skin carcinoma. Although extensive study has explored the mechanism of recurrence and metastasis, the tumorigenesis of melanoma remains unclear. Exploring the tumorigenesis mechanism may help to identify prognostic biomarkers that could serve to guide cancer therapy . Methods We identified differentially expressed genes (DEGs) between patients with primary melanoma and normal skin in three data sets including GSE46517, GSE15605, GSE114445. Functional annotation including KEGG pathway and gene ontology (GO) enrichment analysis was performed by DAVID. Subsequently, protein ‐ protein interaction network of DEGs was developed and the most significant module was constructed as hub genes for further study. ClueGO was used to investigate significant pathways in hub genes. The Kaplan–Meier method was performed to assess prognostic genes. ROC curves were used to describe diagnosis value of hub genes. Then, genes expression and clinical characteristics were validated by TCGA profiles. In addition, we explored the correlation between prognostic genes and immune cell infiltration. Results A total of 308 DEGs and 12 hub genes were identified. GO enrichment results demonstrated a correlation between DEGs and the immune response, inflammatory response and transcriptional control. Hallmark pathways of hub genes including interleukin-10 signaling, chemokine receptors bind chemokine signaling , peptide ligand-binding receptors. Survival analysis and ROC curves suggested that CCL4, CCL5, NMU, CXCL9, CXCL10, CXCL13 were independent prognostic factors (except GAL). Furthermore, prognostic genes were highly expressed in tumor tissue and related to pathological stages and Breslow depth. In addition, the expressions of CCL4, CCL5, CXCL9, CXCL10, CXCL13 were positively correlated with six immune cell infiltration (B-cell, CD8+ T cells, CD4+ T cells, macrophages, Neutrophils, Dendritic cells) and 28 types of TILs such as activated CD8 T cells, regulatory T cells, natural killer T cells while NMU and GAL were negatively correlated with it. Conclusion In summary, this study identified significant hub genes and pathways closely associated with immune infiltrations and prognosis in SKCM patients, which might help us evaluate underlying carcinogenesis progress from skin to melanoma.


2020 ◽  
Author(s):  
Naiqiang Zhu ◽  
Jingyi Hou

Abstract Background: Sarcomas, cancers originating from mesenchymal cells, are comprehensive tumors with poor prognoses, yet their tumorigenic mechanisms are largely unknown. In this study, we characterize infiltrating immune cells and analyze immune scores to identify the molecular mechanism of immunologic response to sarcomas.Method: The “CIBERSORT” algorithm was used to calculate the amount of L22 immune cell infiltration in sarcomas. Then, the “ESTIMATE” algorithm was used to assess the “Estimate,” “Immune,” and “Stromal” scores. Weighted gene co-expression network analysis (WGCNA) was utilized to identify the significant module related to the immune therapeutic target. Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using the “clusterProfiler” package in R for annotation and visualization. Results: Macrophages were the most common immune cells infiltrating sarcomas. The number of CD8 T cells was negatively associated with that of M0 and M2 macrophages, and positively associated with M macrophages in sarcomas samples. The clinical parameters (disease type, gender) significantly increased with higher Estimate, Immune, and Stromal scores, and with a better prognosis. The blue module was significantly associated with CD8 T cells. Functional enrichment analysis showed that the blue module was mainly involved in chemokine signaling and the PI3K-Akt signaling pathway. CD48, P2RY10 and RASAL3 were identified and validated at the protein level. Conclusion: Based on the immune cell infiltration and immune microenvironment, three key genes were identified, thus presenting novel molecular mechanisms of sarcoma metastasis.


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Naiqiang Zhu ◽  
Jingyi Hou

Abstract Background Sarcomas, cancers originating from mesenchymal cells, are comprehensive tumors with poor prognoses, yet their tumorigenic mechanisms are largely unknown. In this study, we characterize infiltrating immune cells and analyze immune scores to identify the molecular mechanism of immunologic response to sarcomas. Method The “CIBERSORT” algorithm was used to calculate the amount of L22 immune cell infiltration in sarcomas. Then, the “ESTIMATE” algorithm was used to assess the “Estimate,” “Immune,” and “Stromal” scores. Weighted gene co-expression network analysis (WGCNA) was utilized to identify the significant module related to the immune therapeutic target. Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using the “clusterProfiler” package in R for annotation and visualization. Results Macrophages were the most common immune cells infiltrating sarcomas. The number of CD8 T cells was negatively associated with that of M0 and M2 macrophages, and positively associated with M macrophages in sarcomas samples. The clinical parameters (disease type, gender) significantly increased with higher Estimate, Immune, and Stromal scores, and with a better prognosis. The blue module was significantly associated with CD8 T cells. Functional enrichment analysis showed that the blue module was mainly involved in chemokine signaling and the PI3K-Akt signaling pathway. CD48, P2RY10 and RASAL3 were identified and validated at the protein level. Conclusion Based on the immune cell infiltration and immune microenvironment, three key genes were identified, thus presenting novel molecular mechanisms of sarcoma metastasis.


2022 ◽  
Author(s):  
Yongsheng Zhang ◽  
Yunlong Wang ◽  
Jichuang Wang ◽  
Kaixiang Zhang

Abstract Bladder cancer (BLCA) is among the most frequent types of cancer. Patients with BLCA have a significant recurrence rate and a poor post-surgery survival rate. Recent research has found a link between tumor immune cell infiltration (ICI) and the prognosis of BLCA patients. However, the ICI picture of BLCA remains unclear. Common gene expression data was obtained by combining the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) expression databases. Two computational algorithms were proposed to unravel the ICI landscape of BLCA patients. The R package "limma" was applied to find differentially expressed genes (DEGs). Principal-component analysis (PCA) was used to calculate the ICI score. A total of 569 common gene expression data were retrieved from TCGA and GEO cohorts. CD8+ T cells were found to have a substantial positive connection with activated memory CD4+ T cells and immune score. On the contrary, CD8+ T cells were found to have a substantial negative connection with Macrophages M0. Thirty-eight DEGs were selected. Two ICI patterns were defined by unsupervised clustering method. Patients of BLCA were separated into two groups. The high ICI score group exhibits better outcome than the low one (p < 0.001). Finally, the group with a high tumor mutation burden (TMB) as well as a high ICI score had the best outcome. (p <0.001). Combining TMB and ICI score resulted in a more accurate survival prediction, suggesting that ICI score could be used as a prognostic marker for BLCA patients.


2020 ◽  
Vol 2020 ◽  
pp. 1-17
Author(s):  
Pan Liao ◽  
Shuzhen Han ◽  
Honglan Qu

Objective. We investigated the expression patterns, potential functions, unique prognostic value, and potential therapeutic targets of E2Fs in brain and CNS cancer and tumor-infiltrating immune cell microenvironments. Methods. We analyzed E2F mRNA expression levels in diverse cancer types via Oncomine and GEPIA databases, respectively. Moreover, we evaluated the prognostic values using GEPIA database and TCGAportal database and the correlation of E2F expression with immune infiltration and the correlation between immune cell infiltration and GBM and LGG prognosis via TIMER database. Then, cBioPortal, GeneMANIA, and DAVID databases were used for mutation analysis, PPI network analysis of coexpressed gene, and functional enrichment analysis. Results. E2F1-8 expression increased in most cancers, including brain and CNS cancer. Higher expression in E2F1, 2, 4, 6, 7, and 8 indicated poor OS of LGG. Higher E2F3–6 and E2F1–8 expressions correlated with poor prognosis and increased immune infiltration levels in CD8+ T cells, macrophages, neutrophils, and DCs in GBM and CD8+ T cells, B cells, CD4+ T cells, neutrophils, macrophages, and DCs in LGG, respectively. Conclusion. E2F1–8 and E2F2–8 could be hopeful prognostic biomarkers of GBM and LGG, respectively. E2F3–6 and E2F1–8 could be likely therapeutic targets in patients with immune cell infiltration of GBM and LGG, respectively.


Sign in / Sign up

Export Citation Format

Share Document